As part of the Leadership team at ClearView Healthcare Partners, Dean has over 15 years’ commercial and research experience in biotechnology, pharmaceuticals and medical devices. He has worked extensively with senior management teams at companies in Europe, North America and Asia to build successful corporate, commercial and R&D strategies and capabilities.
Dean has broad experience supporting companies develop asset, portfolio and corporate strategies, ranging from therapeutic area growth strategy to gene therapy platform development and transactional support. In addition, he brings extensive experience across the global commercial landscape for therapeutics, diagnostics and digital technologies.
Prior to joining ClearView, Dean worked in life sciences consulting for over 10 years following academic research in stem cell biology, epigenetics, transcriptional regulation and cancer.
Dean received his PhD in Stem Cell Biology from the University of Edinburgh and BSc (Hons) in Molecular Genetics from King’s College London.
Debbi Amanti Belanger
Seth Berman
Klaus Bredl
Steven Chao
Rishi Dalsania
Kim Goh
Ketan Kapadia
Philip Kenner
Stuart MacGregor
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Sidnee Pinho
Kristine Hyde
Jim Caruso
Steve Rubman
Lainey Miller
Brian Gibbs
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Dave Konciak
Charles Mathews
Rohit Kumar
Mike Roy
Beko Binder
Jessica Berard
Peter Goldman
Maneesh Gujrati
Austin Hubbert
Jonny Juliano
Owen Im
Andrew Kang
Patrick Kuettner
Joanna Lee
Alexander Lehrman
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Olivia Piccione
Matthew Pfister
Kai-Ming Pu
Sarah Stapleton
Kelsey Yardumian
Vini De Nadai